Ortho Bone II
Natural health product licensed in Canada
- Other names
- Ortho Bone
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80023808
- Status
- Active licence
- Licence date
- 16 February 2011
- Revision date
- 23 October 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Calcium: up to 1,000 mg a day according to the dosing instructions published by Health Canada (10 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 800 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Phosphore: up to 455 mg a day according to the dosing instructions published by Health Canada (10 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 450 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Magnésium: up to 420 mg a day according to the dosing instructions published by Health Canada (10 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 420 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Farine d'os | 100 mg | 1,000,000 µg |
| Boron Source : Citrate de bore | 70 mcg | Not calculated |
| Phosphore Source : Farine d'os | 45.5 mg | 455,000 µg |
| Magnésium Source : Ascorbate de magnésium | 42 mg | 420,000 µg |
| Magnésium Source : Citrate de magnésium | 42 mg | 420,000 µg |
Non-medicinal ingredients
Hypromellose, Farine de glycine soja (fève de soja), Dioxyde de silicium, Sucrose, Huile de noix de coco, Gomme de cellulose, Acide L-aspartique, Glycine, Huile de tournesol, Phosphate de tricalcium, Microcrystalline cellulose, xylitol, Amidon alimentaire, modifié, Maltodextrine, Tocophérols, ascorbate de sodium, Huile de fève de soja, Amidon de maïs modifié, Amidon du riz, Acide citrique, phosphate de dicalcium, Acide stéarique, Hydroxypropylcellulose, Eau purifiée, Gomme arabique, Amidon de maïs, Triglycérides à chaîne moyenne, Huile de maïs, Sodium Stearyl Fumarate
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 10 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones/(and) teeth. Helps to build strong bones/(and) teeth. Helps in the absorption (and use) of calcium and phosphorus. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80023808
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.